The investment objective of the scheme is to generate returns, before expenses, that are commensurate with the performance of the Nifty 500 Healthcare Total Return Index, subject to tracking error.There is no assurance that the investment objective of the scheme will be achieved.
Expert-managed portfolios tailored to your financial goals and risk appetite.
| ETFs | 1M | 3M | 6M | 9M | 1Y | 2Y | 3Y | 4Y | 5Y | 10Y | ALL |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Fund returns | -7.2% | -4.12% | 9.25% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 11.34% |
| Category returns | -2.99% | -4.52% | -3.02% | -5.03% | -4.77% | -2.03% | 9% | 10.98% | 7.45% | 11.5% | N/A |
| Absolute returns | -7.2% | -4.12% | 9.25% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 11.34% |
| Rank within category | 257/268 | 81/252 | 5/241 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| ETFs | 2026 |
|---|---|
| Yearly returns | N/A |
| Q1 returns | N/A |
| Q2 returns | 17.15% |
| Q3 returns | 1% |
| Q4 returns | -4.16% |
| Alpha | -0.0163295 |
| Beta | 0.999 |
| Sharpe Ratio | 0.343339 |
| Sortino Ratio | 0.769824 |
| R-Squared | 0.9869 |
| Tracking Error | 0.0126 |
| Downside Risk | 7.4667 |
| Std. Deviation (Annualised) | 14.6573 |
| ETFs | 1M | 3M | 6M | 9M | 1Y | 3Y | 5Y | 10Y | ALL | Fund Size (Cr) | Exp. Ratio | Sharpe | Risk |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Motilal Oswal BSE Healthcare ETF | -7.16% | -4.01% | 10.11% | 12.75% | 6.7% | 19.48% | N/A | N/A | 19.41% | 44.40 | 0.36 | 0.30 | Very High |
| Nippon India Nifty Pharma ETF | -4.12% | -0.09% | 14.11% | 16.17% | 15.52% | 19.28% | 12.79% | N/A | 12.07% | 1,736.44 | 0.23 | 0.30 | Very High |
| Motilal Oswal BSE Enhanced Value ETF | -3.37% | -6.03% | -9.38% | -9.5% | -0.01% | 18.7% | N/A | N/A | 26.28% | 146.61 | 0.43 | 0.20 | Very High |
| DSP Nifty PSU Bank ETF | -0.29% | -1.08% | -5.84% | -7.11% | 9.24% | 18.66% | N/A | N/A | 20.49% | 1,434.17 | 0.16 | 0.15 | Very High |
| ICICI Prudential Nifty PSU Bank ETF | -0.32% | -1.15% | -6.01% | -7.33% | 8.91% | 18.53% | N/A | N/A | 26.2% | 118.61 | 0.41 | 0.15 | Very High |
| Nippon India ETF Nifty PSU Bank BeES | -0.32% | -1.17% | -6.04% | -7.39% | 8.81% | 18.35% | 25.56% | 10.01% | 6.93% | 3,932.00 | 0.51 | 0.14 | Very High |
| Kotak Nifty PSU Bank ETF | -0.32% | -1.17% | -6.06% | -7.4% | 8.79% | 18.33% | 25.56% | 9.94% | 6.36% | 2,490.74 | 0.51 | 0.14 | Very High |
| Aditya Birla Sun Life Nifty Healthcare ETF | -6.38% | -4.45% | 7.53% | 9.15% | 4.95% | 18.01% | 0% | N/A | 12.85% | 74.67 | 0.20 | 0.27 | Very High |
| ICICI Prudential Nifty Healthcare ETF | -6.38% | -4.44% | 7.56% | 9.19% | 5% | 17.87% | 12.38% | N/A | 12.86% | 231.43 | 0.16 | 0.27 | Very High |
| Mirae Asset Nifty 500 Healthcare ETF Current | -7.2% | -4.12% | 9.25% | 0% | N/A | N/A | N/A | N/A | 11.34% | 15.36 | 0.35 | 0.34 | Very High |
| Name | Sector | Instrument | Assets % |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 10.13% |
| Divi's Laboratories Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 8.76% |
| Apollo Hospitals Enterprise Ltd. | Healthcare Services | Domestic Equities | 6.24% |
| Laurus Labs Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 5.72% |
| Cipla Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 5.62% |
| Dr. Reddy's Laboratories Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 5.58% |
| Torrent Pharmaceuticals Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 5.24% |
| Max Healthcare Institute Ltd. | Healthcare Services | Domestic Equities | 5.13% |
| Lupin Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 3.66% |
| Aurobindo Pharma Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 3.43% |
| Fortis Healthcare Ltd. | Healthcare Services | Domestic Equities | 2.98% |
| Glenmark Pharmaceuticals Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 2.61% |
| Alkem Laboratories Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 2.31% |
| Zydus Lifesciences Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 2.14% |
| Mankind Pharma Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 2.10% |
| Ipca Laboratories Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 1.98% |
| Biocon Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 1.91% |
| Gland Pharma Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 1.71% |
| Sai Life Sciences Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 1.56% |
| Krishna Institute of Medical Sciences Ltd | Healthcare Services | Domestic Equities | 1.48% |
| Aster DM Quality Care Ltd. | Healthcare Services | Domestic Equities | 1.38% |
| Neuland Laboratories Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 1.36% |
| Wockhardt Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 1.30% |
| Acutaas Chemicals Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 1.26% |
| Ajanta Pharma Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 1.22% |
| Dr. Lal Pathlabs Ltd. | Healthcare Services | Domestic Equities | 1.15% |
| Abbott India Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 1.04% |
| Piramal Pharma Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.95% |
| Granules India Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.93% |
| Narayana Hrudayalaya Ltd. | Healthcare Services | Domestic Equities | 0.92% |
| Global Health Ltd. | Healthcare Services | Domestic Equities | 0.90% |
| Onesource Specialty Pharma Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.89% |
| Glaxosmithkline Pharmaceuticals Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.85% |
| Anthem Biosciences Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.69% |
| Emcure Pharmaceuticals Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.60% |
| Natco Pharma Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.55% |
| Cohance Lifesciences Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.54% |
| Vijaya Diagnostic Centre Ltd. | Healthcare Services | Domestic Equities | 0.52% |
| Syngene International Ltd. | Healthcare Services | Domestic Equities | 0.51% |
| Rainbow Children's Medicare Ltd. | Healthcare Services | Domestic Equities | 0.48% |
| Poly Medicure Ltd. | Healthcare Equipment & Supplies | Domestic Equities | 0.47% |
| Rubicon Research Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.43% |
| Caplin Point Laboratories Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.40% |
| Concord Biotech Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.34% |
| TREPS | Cash & Cash Equivalents and Net Assets | 0.13% | |
| Net Receivables / (Payables) | Cash & Cash Equivalents and Net Assets | -0.09% | |
| Total | 100.00% | ||
Ms. Ekta Gala has over 3 years of experience as a dealer. Prior to this assignment, Ms. Ekta Gala was associated with ICICI Prudential Asset Management Company Ltd.
Mr. Ritesh Patel has over 10 years of experience in Commodities market. Prior to joining Mirae Asset Investment Managers (India) Private Limited, Mr. Patel has worked with companies like Aditya Birla Money Ltd, IIFL Securities, Ventura Securities, Choice Broking Pvt. Ltd and Waves research.
Get personalized portfolio management services designed to grow and protect your wealth.
ChatGPT
Claude
Perplexity
